Treatment of Vertigo
The primary treatment for vertigo should be targeted to the underlying cause, with canalith repositioning procedures being the first-line treatment for BPPV (80-90% success rate), vestibular suppressants for acute symptomatic relief, and vestibular rehabilitation for long-term management. 1
Diagnosis and Classification
Before initiating treatment, it's essential to determine the cause of vertigo:
Common causes of vertigo:
- Benign Paroxysmal Positional Vertigo (BPPV): 42% of cases
- Vestibular neuritis: 41% of cases
- Menière's disease: 10% of cases
- Migraine-associated vertigo: up to 14% of cases
- Vascular causes: 3% of cases 1
Diagnostic approach:
- Dix-Hallpike test: Gold standard for diagnosing BPPV
- HINTS examination (Head-Impulse, Nystagmus, Test of Skew): More sensitive than early MRI for detecting stroke in patients with vertigo (100% vs 46%) 1
- Audiologic testing: For patients with unilateral tinnitus, persistent symptoms, or hearing difficulties
Treatment Algorithm
1. BPPV Treatment
- First-line: Canalith repositioning procedures (Epley, Semont, or Lempert maneuvers) with 80-90% success rates after 1-2 treatments 1, 2
- Follow-up: Patient education about high recurrence risk (10-18% at 1 year, up to 36% long-term)
2. Vestibular Neuritis/Labyrinthitis Treatment
- Acute management:
- Long-term management: Vestibular rehabilitation exercises
3. Menière's Disease Treatment
- First-line: Low-salt diet and diuretics (reduce endolymph volume and vertigo attacks by 56% compared to placebo) 1, 3
- Second-line: Intratympanic steroid injections for cases not responsive to oral treatment 1
- Refractory cases: Transtympanic gentamicin for patients with non-usable hearing 1
4. Vestibular Migraine Treatment
- Prophylaxis: Beta-blockers, anticonvulsants, or antidepressants 1
- Acute treatment: Similar to migraine headache management
Pharmacological Management
Vestibular suppressants (for short-term use only):
Important caution: Vestibular suppressants should be used for short-term symptomatic relief only, as long-term use can delay vestibular compensation 1
Side effects to monitor:
- Drowsiness: Use caution when driving or operating machinery
- Anticholinergic effects: Use with care in patients with asthma, glaucoma, or prostate enlargement 4
Non-Pharmacological Approaches
Vestibular rehabilitation:
- Can be self-administered or clinician-guided
- Particularly beneficial for elderly patients
- May decrease recurrence rates 1
Physical activity:
- Regular cardio-exercise for at least 30 minutes twice weekly
- Vestibular electrical stimulation: Superficial paravertebral electrical stimulation of neck muscles 2
Fall prevention:
- Home safety assessment
- Activity restrictions until vertigo resolves, especially for elderly patients 1
Monitoring and Follow-up
Clinicians should document resolution, improvement, or worsening of vertigo, tinnitus, and hearing loss, as well as any change in quality of life after treatment 5. This follow-up allows for:
- Evaluation of treatment effectiveness
- Identification of patients who need increased or decreased intensity of therapy
- Reduction of ineffective therapy use
- Early detection of disease progression
Special Considerations
Pregnancy: Metoclopramide can be used under supervision 1
Medication-induced vertigo: Several medication classes can cause vertigo as an adverse effect, particularly in patients with renal impairment or advanced age 1
Central causes: Require urgent evaluation and treatment if suspected based on neurological signs or HINTS examination 1
Surgical options: Reserved for patients who have not benefited from less definitive therapy and have non-usable hearing 6
The treatment of vertigo requires a targeted approach based on accurate diagnosis, with the goal of controlling symptoms, improving quality of life, and addressing the underlying cause when possible.